Get App Open
In App
Lending
Lending
Open App
you are here:
Success
Alert
Please select a Day.
Info

Shilpa Medicare Ltd.

Sector : Healthcare | Industry : Pharmaceuticals & Drugs

43/100
356.00
-1.20 (-0.34%)

As on 17 Oct, 2025 | 03:48

Open Trading A/c
Day Range
348.15
358.75
L H
52 Week Range
277.50
500.00
L H
Volume
209,957
*
i

* BSE Market Depth (17 Oct 2025)

BUY SELL
QTY PRICE PRICE QTY
10 355.00 357.00 71
1 354.95 358.25 10
5 354.00 358.40 50
1 353.00 359.00 200
76 351.00 359.25 10
0 Total Total 0
Bid / Ask
0.00 / 0.00
43/100
356.20
-1.60 (-0.45%)

As on 17 Oct, 2025 | 04:01

Open Trading A/c
Day Range
348.40
358.80
L H
52 Week Range
265.25
501.60
L H
Volume
25,409
*
i

* BSE Market Depth (17 Oct 2025)

BUY SELL
QTY PRICE PRICE QTY
10 355.00 357.00 71
1 354.95 358.25 10
5 354.00 358.40 50
1 353.00 359.00 200
76 351.00 359.25 10
0 Total Total 0
Bid / Ask
0.00 / 0.00
NSE
MC Essentials
65% Pass
MC Technicals
i
This represents current trend.Click here for disclaimer.
MC Insights

Average Financial Strength, Average Growth Trend Stock Priced at High Valuations

Financials
    Ownerships
      Industry Comparison
        Others
          Open 355.45
          Previous Close 357.20
          Volume 209,957.00
          Value (Lacs) 747.45
            VWAP 353.12
          Beta
          Mkt Cap (Rs. Cr.) 6,963
          High 358.75
          Low 348.15
          UC Limit 392.90
          LC Limit 321.50
          52 Week High 500.00
          52 Week Low 277.50
          Face Value 1.00
          All Time High 500.00
          All Time Low 22.63
          20D Avg Volume 319,361
          20D Avg Delivery(%) 46.71
          Book Value Per Share 121.29
          Dividend Yield 0.28
          TTM EPS See historical trend 5.68 (+81.87% YoY)
          TTM PE See historical trend 62.68 (Average PE)
          P/B See historical trend 2.94 (Low P/B)
          Sector PE 39.50

          Advanced Chart

          Click here to expand

          *Delayed by 20 seconds.

          Forecast                                                

          Earnings Forecast

          Actuals Estimates
          ANNUALLY 
          (Rs.) 

          Valuations

          Consensus Recommendations

          • Buy
          • Outperform
          • Hold
          • Underperform
          • Sell

          Hits/Misses

          QUARTERLY (Rs.)
          # of Beats
          # of Misses
          # of Inline
          # of Beats
          # of Misses
          # of Inline
          # of Beats
          # of Misses
          # of Inline

          MC Insights

          Stock Score

          43/100
          Average Financial Strength, Average Growth Trend Stock Priced at High Valuations

          Get detailed analysis with Moneycontrol Stock Insights.

          Get detailed analysis with Moneycontrol Stock Insights.

          Price
          • 28.80% away from 52 week high

          Financials
          Piotroski Score
          i

          indicates

          Industry Comparison
          • Market Cap - Above Median

          Shareholding Pattern
          • Promoter holding remains unchanged at 44.23% in Sep 2025 qtr.

          MC Technicals

          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          Moving Averages --
          Technical Indicators --
          Moving Averages Crossovers --

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

          Pivot levels

          R1 - - Pivot
          - -
          S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

          Moving Averages
          Days
          5 - -
          10 - -
          20 - -
          50 - -
          100 - -
          200 - -
          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          Moving Averages --
          Technical Indicators --
          Moving Averages Crossovers --

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

          Pivot levels

          R1 - - Pivot
          - -
          S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

          Moving Averages
          Days
          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          Moving Averages --
          Technical Indicators --
          Moving Averages Crossovers --

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

          Pivot levels

          R1 - - Pivot
          - -
          S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

          Moving Averages
          Days

          Price and Volume

          Price Performance
          1 Week
          --%
          1 Month
          --%
          3 Months
          --%
          YTD
          --%
          1 Year
          --%
          3 Years
          --%
          Volume Analysis
          • Volume
          • Delivery

          SEASONALITY ANALYSIS

          8 out of 16 years Shilpa Medicare has given positive returns in October.

          Month Max. Positive Change(%) Avg. Positive Change(%) Max. Negative Change(%) Avg. Negative Change(%) Average Change(%)
          October 27.79% (2013) 8.46% -19.97% (2020) -7.16% 0.65%

          Forum

          Community Sentiments

          • 100% BUY
          • 0% SELL
          • 0% HOLD
          100%
          of moneycontrol users recommend buying Shilpa

          What's your call on Shilpa today?

          Read 0 investor views

          BUY SELL HOLD

          Broker Research

          No Data For Broker Research.

          Deals

          23 Jan, 2025

          Ubs Ag

          Qty 163006 Price 818.05 % Traded 0.17
          23 Jan, 2025

          Ubs Principal Capital Asia Limited

          Qty 163006 Price 818.05 % Traded 0.17

          *Transaction of a minimum quantity of 500,000 shares or a minimum value of Rs 5 crore.

          21 Mar, 2025

          The Vanguard Group Inc Ac Vanguard Total International Stock Index Fund

          Qty 547853 Price 683.03 % Traded 0.56

          *A bulk deal is a trade where total quantity of shares bought or sold is more than 0.5% of the equity shares of a company listed on the exchange.

          Financials

          • Revenue
          • Net Profit
          • EPS
          • BVPS
          • ROE
          • Debt to Equity
          • Revenue
          • Net Profit
          • EPS
          • BVPS
          • ROE
          • Debt to Equity

          Shareholding

          PEERS

          Company Name Price % Chg MCap(Cr) TTM PE P/B ROE(%) 1 Yr Perform(%) Net Profit(Rs.) Net Sales(Rs.) Debt to Equity
          Shilpa 356.00 -0.34 6,962.71 62.68 2.94 3.30 -17.10 79 1,286 0.25
          Sun Pharma 1,679.10 1.21 402,872.33 38.84 5.83 15.13 -11.14 10,980 52,578 0.03
          Divis Labs 6,621.50 0.32 175,780.02 76.22 12.81 14.63 8.95 2,191 9,360 0.00
          Cipla 1,577.60 0.52 127,433.12 23.63 4.49 16.90 1.21 5,291 27,547 0.00
          Torrent Pharma 3,584.30 1.43 121,309.00 60.60 16.17 25.17 5.52 1,911 11,516 0.40

          About the Company

          Shilpa Medicare Ltd produces and exports consistently high-quality Active Pharmaceutical Ingredients Fine Chemicals, intermediates, herbal products and speciality chemical products using sophisticated technology, meticulously following international specifications.The product range of the company includes Oncology AP`s-Anastrozole,Bicalutamide,Carboplatin ,Gemcitabine HCI, Irinotecan HCl Trihydrate,etc.General APIs-Ambroxol HCl,Ticlopidine HCl,Buflomedil HCl ,Nifedipine ,Lamivudine ,etc.PRODUCTS UNDER DEVELOPMENT (Oncology)- Bendamustine Cladribine, Decitabine Disodium Pamidronate, Epirubicin Exemustane, Fludarabine Phosphate Idarubicine,etc.NUTRITIONAL SUPPLEMENTS-Chromium picolinate Chromium polynicotinate.DRUG INTERMEDIATES-Trans-4-amino cyclohexanol,2-Amino-3,5-dibromobenzaldehyde,1,3,5-Trimethoxy Benzene ,etc..The company also engagged in the business of Power, Bulk Drugs and Intermediates.
          {"success":1,"data":{"address":{"address1":"12-6-214\/A-1,","address2":"Shilpa House,,Hyderabad Road,","city":"Raichur","state":"Karnataka","pincode":"584135","telephone1":"08532-238704","telephone2":"","fax1":"08532-238876","fax2":"","email":"info@vbshilpa.com","web":"http:\/\/www.vbshilpa.com"},"management":[{"name":"Omprakash Inani","designation":"Chairman"},{"name":"Vishnukant C Bhutada","designation":"Managing Director"},{"name":"Kalakota Sharath Reddy","designation":"Whole Time Director"},{"name":"Hetal Madhukant Gandhi","designation":"Independent Director"},{"name":"Arvind Vasudeva","designation":"Independent Director"}],"registrars":{"name":"KFIN Technologies Pvt. Ltd.","address1":"Selenium Tower B, Plot No. 31-32,","address2":"Gachibowli, Financial District, \nNanakramguda,Seri","address3":"","address4":"","telephone":"040-67161500, 67162222, 33211000","fax":"040-23420814, 23001153","email":"einward.ris@karvy.com","internet":"http:\/\/www.kfintech.com","city":"Hyderabad","state":"Telangana","pincode":"500032"},"listing":[{"name":"BSE 100","value":"No"},{"name":"BSE 200","value":"No"},{"name":"SENSEX","value":"No"},{"name":"CNX MIDCAP 200","value":"No"},{"name":"NIFTY 50","value":"No"},{"name":"BSE 500","value":"No"},{"name":"Nifty 200","value":"No"}],"details":{"bseId":"530549","nseId":"SHILPAMED","series":"EQ","isinid":"INE790G01031"}}}
          • Registered Office

          • Registrars

            • Address

              Selenium Tower B, Plot No. 31-32,,Gachibowli, Financial District, Nanakramguda,Seri

            • City

              Hyderabad 500032

            • State

              Telangana

            • Tel. No.

              040-67161500, 67162222, 33211000

            • Fax No.

              040-23420814, 23001153

            • Email

              einward.ris@karvy.com

            • Internet

              http://www.kfintech.com

          • Management

            • Omprakash Inani

              Chairman

            • Vishnukant C Bhutada

              Managing Director

            • Kalakota Sharath Reddy

              Whole Time Director

            • Hetal Madhukant Gandhi

              Independent Director

            • Arvind Vasudeva

              Independent Director

          • Included In

            • BSE 100

              No

            • BSE 200

              No

            • SENSEX

              No

            • CNX MIDCAP 200

              No

            • NIFTY 50

              No

            • BSE 500

              No

            • Nifty 200

              No

          • Details

            • BSE:

              530549

            • NSE:

              SHILPAMED

            • Series

              EQ

            • ISIN

              INE790G01031